Tradewinds Capital Management, LLC Editas Medicine, Inc. Transaction History

Tradewinds Capital Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Oct 26, 2020	SELL	$28.06 - $37.16 $2,806 - $3,715	-100 Closed	0 $0
Q1 2020 May 11, 2020	SELL	$14.88 - $32.78 $505 - $1,114	-34 Reduced 25.37%	100 $2,000
Q4 2019 Feb 04, 2020	BUY	$19.49 - $32.63 $662 - $1,109	34 Added 34.0%	134 $4,000
Q1 2019 Apr 23, 2019	SELL	$19.43 - $26.41 $3,439 - $4,674	-177 Reduced 63.9%	100 $2,000
Q3 2017 Nov 03, 2017	BUY	$15.81 - $24.01 $4,379 - $6,650	277	277 $7,000

227

54.3M

412K

355K

Ticker EDIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,737,200
Market Cap $88M
Description
Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...

Get notified when there are updates to the investment portfolio of Tradewinds Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Tradewinds Capital Management, LLC with notifications on news.